J&J Medtech’s FDA-Cleared DUALTO System Prepares For Future Use With OTTAVA Robotic Platform

Future-Ready Surgical Energy Platform Designed For Flexibility, Precision And Robotic Integration

DUALTO’s double-module option provides enhanced flexibility while cutting down on equipment clutter. Compared to traditional setups, the system reduces OR footprint by 46%, helping staff reclaim space and optimize surgical workflows.

Designed to consolidate multiple energy modalities into a single platform, DUALTO also incorporates connectivity features and modular configurations that support broader digital integration.
Key Takeaways
  • DUALTO is FDA-cleared to consolidate four energy modalities into one system, with a modular, dual-surgeon configuration and a single touchscreen interface for streamlined workflows. 

      J&J MedTech’s DUALTO Energy System, recently cleared by the FDA, is not only built to replace multiple legacy generators–it’s also...

      Read the full article – start your free trial today!

      Join thousands of industry professionals who rely on Medtech Insight for daily insights

      • Start your 7-day free trial
      • Explore trusted news, analysis, and insights
      • Access comprehensive global coverage
      • Enjoy instant access – no credit card required

      More from Robotic Surgery

      J&J MedTech’s Digital Head Pushes for Smarter, Standardized ORs With AI and Open Tech

       
      • By 

      J&J’s global head of MedTech Digital envisions AI-powered connected operating suites within a decade. In an interview with Medtech Insight, Shan Jegatheeswaran discusses how J&J, together with partners like NVIDIA and AWS, is laying the foundation for open platforms for standardized surgeries.

      Olympus, Revival Co-Found Swan In $458M Deal, Face Tech and Regulatory Hurdles

       
      • By 

      Olympus and Revival Healthcare Capital have launched Swan Endosurgical in a $458m milestone-based joint venture to develop a robotic platform for endoluminal surgery. The deal combines Olympus’ GI expertise with Revival’s start-up model, but will face technical and regulatory hurdles.

      Intuitive Surgical Sees Early Wins With Da Vinci 5, Lifts FY25 Guidance As Tariff Impact Eases

       
      • By 

      For the full year, the company now expects tariffs to increase the cost of sales by approximately 1% of revenue, plus or minus 20 basis points. This is lower than the previous estimate of approximately 1.7% of revenue. The updated gross margin guidance for 2025 is 66%-67%, up from 65%-66.5%.

      ForSight Sets Its Sights On Automating Delicate Eye Procedures

       
      • By 

      ForSight Robotics is developing a robotic platform to automate cataract and other eye surgeries, aiming to ease surgeon strain and expand access. Backed by $200m in total funding, it's targeting a first human surgery using Oryom by year-end and is in discussions with US FDA.

      More from Medtech Insight

      UK MHRA Takes Stock, Seeks CMSO And Reveals Device Innovation Early Access Thinking

       
      • By 

      Evolution of the MHRA and its offering to medtechs continues, with the hunt for a visionary chief medical and scientific officer and release of outline plans on early access to innovative devices, building on IDAP learnings.

      US FDA Webinar Highlights 506J Expectations Amid Ongoing Supply Chain Vulnerabilities

       
      • By 

      A recent CDRH Learn module urges medical device manufacturers to report potential shortages early, even outside emergencies, to help prevent disruptions. Recent natural disasters underscore the need for resilient supply chains, and reported shortages may be added to an FDA list.

      J&J MedTech’s Digital Head Pushes for Smarter, Standardized ORs With AI and Open Tech

       
      • By 

      J&J’s global head of MedTech Digital envisions AI-powered connected operating suites within a decade. In an interview with Medtech Insight, Shan Jegatheeswaran discusses how J&J, together with partners like NVIDIA and AWS, is laying the foundation for open platforms for standardized surgeries.